agilon health, inc. (AGL) EBITDA
- 2026-06-30: Basis Reported; EBITDA $18.63M*; Operating income $11.77M; Depreciation and amortization $6.86M*.
- 2026-03-31: Basis Reported; EBITDA $10.78M; Operating income (m); Depreciation and amortization (m).
- 2025-12-31: Basis Reported; EBITDA -$186.86M; Operating income (m); Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA -$123.84M*; Operating income -$131.27M; Depreciation and amortization $7.43M*.
Complete source-backed ebitda history.
- Available history
- 2019-12-31 to 2026-03-31
- Data captured
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2026-06-30 | Reported | $18.63M* | $11.77M | $6.86M* | $1.49B | 1.25%* | $3.45M* | -$57.30M* | (m) | (m) | (m) | -$375.00K |
|---|
| 2026-03-31 | Reported | $10.78M | (m) | (m) | (m) | 0.76% | $3.10M | $23.73M | (m) | (m) | (m) | $28.00K |
|---|
| 2025-12-31 | Reported | -$186.86M | (m) | (m) | (m) | -11.91% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2025-09-30 | Reported | -$123.84M* | -$131.27M | $7.43M* | $1.44B | -8.63%* | $3.17M* | -$18.15M* | (m) | (m) | (m) | -$331.00K |
|---|
| 2025-06-30 | Reported | -$108.71M* | -$116.03M | $7.32M* | $1.39B | -7.79%* | $3.25M* | -$35.09M* | (m) | (m) | (m) | $62.00K |
|---|
| 2025-03-31 | Reported | -$15.23M | (m) | (m) | (m) | -0.99% | $3.85M | -$31.99M | (m) | (m) | (m) | $196.00K |
|---|
| 2024-12-31 | Reported | -$101.61M | (m) | (m) | (m) | -6.67% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2024-09-30 | Reported | -$127.29M* | -$133.51M | $6.22M* | $1.45B | -8.77%* | $3.53M* | -$7.70M* | (m) | (m) | (m) | -$590.00K |
|---|
| 2024-06-30 | Reported | -$37.44M* | -$43.34M | $5.91M* | $1.48B | -2.52%* | $3.31M* | -$18.72M* | (m) | (m) | (m) | $417.00K |
|---|
| 2024-03-31 | Reported | -$1.33M | (m) | (m) | (m) | -0.08% | $3.14M | -$47.78M | (m) | (m) | (m) | -$133.00K |
|---|
| 2023-12-31 | Reported | -$159.15M | (m) | (m) | (m) | -15.07% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2023-09-30 | Reported | -$33.98M* | -$39.29M | $5.31M* | $1.14B | -2.99%* | $4.09M* | -$13.02M* | (m) | (m) | (m) | $1.21M |
|---|
| 2023-06-30 | Reported | -$23.44M* | -$28.96M | $5.51M* | $1.07B | -2.19%* | $4.09M* | -$21.20M* | (m) | (m) | (m) | $1.07M |
|---|
| 2023-03-31 | Reported | $4.61M | (m) | (m) | (m) | 0.44% | $3.72M | -$60.81M | (m) | (m) | (m) | -$1.76M |
|---|
| 2022-12-31 | Reported | -$50.16M | (m) | (m) | (m) | -13.56% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2022-09-30 | Reported | -$26.07M* | -$29.52M | $3.45M* | $694.86M | -3.75%* | $3.43M* | $2.65M* | (m) | (m) | (m) | $559.00K |
|---|
| 2022-06-30 | Reported | -$18.01M* | -$21.05M | $3.04M* | $670.13M | -2.69%* | $4.46M* | -$60.26M* | (m) | (m) | (m) | $580.00K |
|---|
| 2022-03-31 | Reported | $2.63M | (m) | (m) | (m) | 0.40% | $4.05M | -$23.23M | (m) | (m) | (m) | -$71.00K |
|---|
| 2021-12-31 | Reported | -$22.53M | (m) | (m) | (m) | -14.93% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2021-09-30 | Reported | -$31.66M* | -$35.60M | $3.94M* | $458.61M | -6.90%* | $2.52M* | -$19.14M* | (m) | (m) | (m) | $256.00K |
|---|
| 2021-06-30 | Reported | -$294.75M* | -$298.36M | $3.61M* | $498.96M | -59.07%* | $468.00K* | -$39.29M* | (m) | (m) | (m) | $435.00K |
|---|
| 2021-03-31 | Reported | -$8.63M | (m) | (m) | (m) | -2.09% | $178.00K | -$40.83M | (m) | (m) | (m) | $16.00K |
|---|
| 2020-12-31 | Reported | -$35.99M | (m) | (m) | (m) | -11.21% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2020-09-30 | Reported | -$6.34M* | -$9.84M | $3.50M* | $312.68M | -2.03%* | $316.00K* | -$4.37M* | (m) | (m) | (m) | $35.00K |
|---|
| 2020-06-30 | Reported | $2.23M* | -$1.25M | $3.48M* | $293.59M | 0.76%* | $596.00K* | -$9.37M* | (m) | (m) | (m) | $39.00K |
|---|
| 2020-03-31 | Reported | -$2.47M | (m) | (m) | (m) | -0.85% | $345.00K | -$26.13M | (m) | (m) | (m) | (m) |
|---|
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2025-12-31 | Reported | -$434.64M | (m) | (m) | (m) | -7.33% | $13.24M | -$105.76M | (m) | (m) | (m) | $1.25M |
|---|
| 2024-12-31 | Reported | -$267.67M | (m) | (m) | (m) | -4.42% | $13.25M | -$57.78M | (m) | (m) | (m) | $1.45M |
|---|
| 2023-12-31 | Reported | -$211.97M | (m) | (m) | (m) | -4.91% | $15.83M | -$156.20M | (m) | (m) | (m) | $791.00K |
|---|
| 2022-12-31 | Reported | -$91.61M | (m) | (m) | (m) | -3.84% | $15.43M | -$130.81M | (m) | (m) | (m) | $1.64M |
|---|
| 2021-12-31 | Reported | -$357.57M | (m) | (m) | (m) | -23.50% | $6.56M | -$148.16M | (m) | (m) | (m) | $886.00K |
|---|
| 2020-12-31 | Reported | -$42.57M | (m) | (m) | (m) | -3.49% | $1.77M | -$53.20M | (m) | (m) | (m) | $865.00K |
|---|
| 2019-12-31 | Reported | -$65.16M | (m) | (m) | (m) | -8.20% | $2.89M | -$103.86M | (m) | (m) | (m) | -$232.00K |
|---|